Lastly, we could confirm the presence of increased levels of AAbs against PNMA2, TARS and C1QBP in the serum of POAG patients that deserve to be further analysed as potential glaucoma biomarkers. This evidence concerns the gene C1QBP and open-angle glaucoma.